贝伐单抗联合化疗用于非小细胞肺癌：在寻找几个合适的人？ - Suppr | 超能文献

Bevacizumab/chemotherapy in non-small-cell lung cancer: looking for a few good men?

作者信息

Herbst Roy S

出版信息

Clin Lung Cancer. 2008 Mar;9(2):75-6. doi: 10.3816/CLC.2008.n.011.

DOI:10.3816/CLC.2008.n.011

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Bevacizumab/chemotherapy in non-small-cell lung cancer: looking for a few good men?贝伐单抗联合化疗用于非小细胞肺癌：在寻找几个合适的人？

Clin Lung Cancer. 2008 Mar;9(2):75-6. doi: 10.3816/CLC.2008.n.011.

2

Bevacizumab for non-small-cell lung cancer.贝伐单抗用于非小细胞肺癌。

N Engl J Med. 2007 Mar 29;356(13):1373-4; author reply 1374-5.

3

Bevacizumab for non-small-cell lung cancer.贝伐单抗用于非小细胞肺癌。

N Engl J Med. 2007 Mar 29;356(13):1373; author reply 1374-5. doi: 10.1056/NEJMc070042.

4

Bevacizumab for non-small-cell lung cancer.贝伐单抗用于非小细胞肺癌。

N Engl J Med. 2007 Mar 29;356(13):1374; author reply 1374-5.

5

Bevacizumab for non-small-cell lung cancer.贝伐单抗用于非小细胞肺癌

N Engl J Med. 2007 Mar 29;356(13):1373; author reply 1374-5.

6

Improved survival with addition of bevacizumab to paclitaxel and carboplatin in elderly patients with non-small-cell lung cancer.在老年非小细胞肺癌患者中，在紫杉醇和卡铂基础上加用贝伐单抗可提高生存率。

J Clin Oncol. 2008 Apr 20;26(12):2063-4; author reply 2064-5. doi: 10.1200/JCO.2008.16.3337.

7

A trial-based assessment of the cost-utility of bevacizumab and chemotherapy versus chemotherapy alone for advanced non-small cell lung cancer.一项基于试验的评估：贝伐珠单抗联合化疗对比单纯化疗治疗晚期非小细胞肺癌的成本效用分析。

Value Health. 2011 Sep-Oct;14(6):836-45. doi: 10.1016/j.jval.2011.04.004. Epub 2011 Jun 24.

8

Pemetrexed plus bevacizumab for second-line therapy of non-small-cell lung cancer: the importance of patient selection.培美曲塞联合贝伐单抗用于非小细胞肺癌二线治疗：患者选择的重要性。

J Clin Oncol. 2010 Mar 10;28(8):e131; author reply e132. doi: 10.1200/JCO.2009.26.7351. Epub 2010 Jan 25.

9

The use of bevacizumab in colorectal, lung, breast, renal and ovarian cancer: where does it fit?贝伐单抗在结直肠癌、肺癌、乳腺癌、肾癌及卵巢癌中的应用：其适用情况如何？

Eur J Cancer. 2008 Nov;44(16):2350-6. doi: 10.1016/j.ejca.2008.07.042. Epub 2008 Sep 11.

10

In focus: non-small cell lung cancer: E1505.聚焦：非小细胞肺癌：E1505。

Clin Adv Hematol Oncol. 2007 Mar;5(3):206-8.

引用本文的文献

1

The high diagnostic accuracy of combined test of thyroid transcription factor 1 and Napsin A to distinguish between lung adenocarcinoma and squamous cell carcinoma: a meta-analysis.甲状腺转录因子1和Napsin A联合检测鉴别肺腺癌与肺鳞癌的高诊断准确性：一项荟萃分析

PLoS One. 2014 Jul 8;9(7):e100837. doi: 10.1371/journal.pone.0100837. eCollection 2014.

2

Dual color multiplex TTF-1 + Napsin A and p63 + CK5 immunostaining for subcategorizing of poorly differentiated pulmonary non-small carcinomas into adenocarcinoma and squamous cell carcinoma in fine needle aspiration specimens.双色多重TTF-1 + Napsin A和p63 + CK5免疫染色用于在细针穿刺标本中将低分化肺非小细胞癌亚分类为腺癌和鳞状细胞癌。

Cytojournal. 2012;9:10. doi: 10.4103/1742-6413.94570. Epub 2012 Mar 31.